Beaconcure Inc. and Phastar Inc. have forged a strategic partnership to enhance clinical review processes in clinical trials by combining Beaconcure's AI-enabled clinical data validation and automation technology with Phastar’s expertise in biometrics. Ilan Carmeli, Beaconcure's COO, lauded the collaboration, highlighting the integration of Verify, Beaconcure’s platform, into Phastar’s operations. This integration aims to minimize human error, enhance efficiency, and foster transparency, thereby expediting study validation and approvals. The partnership is set to transform clinical reviews, shorten review cycles, and accelerate treatment delivery through improved data integrity and streamlined decision-making processes.
Ping-Chung Chang, Phastar's Head of Business Transformation, emphasized the partnership's significance in meeting customer needs and driving innovations in clinical data reporting and reviewing. By leveraging Verify, Phastar aims to enhance clinical review processes with automatically generated audit trails, streamlined data reporting, and optimized workflow management. Together, Beaconcure and Phastar are committed to setting new industry standards, increasing speed, and ensuring compliance in clinical trials, as Christine Oliver, Beaconcure's CEO, affirms the commitment to continuous innovation and dynamic system creation through this partnership.
No comments yet